Plainsboro, NJ, United States of America

Ming Lu

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Helsinn Healthcare Sa. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Lu. Retrieved from https://idiyas.com/inventor/ming-lu-vpswupdc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Ming Lu

Introduction

Ming Lu is a prominent inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of medical treatments, particularly in relation to cancer care. With a total of 4 patents to his name, his work continues to impact the medical community.

Latest Patents

Ming Lu's latest patents focus on medical treatments based on anamorelin. He has developed methods for treating cancer-related conditions using this innovative compound. His research aims to improve the quality of life for patients suffering from various forms of cancer.

Career Highlights

Ming Lu is currently associated with Helsinn Healthcare SA, where he applies his expertise in medical research and development. His work at the company has been instrumental in advancing treatment options for cancer patients.

Collaborations

Ming Lu has collaborated with notable colleagues, including William Mann and John Friend. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ming Lu's contributions to medical treatments, particularly through his patents on anamorelin, highlight his dedication to improving cancer care. His work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…